The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Multiple subcutaneous doses safe and well-tolerated ... therapy obviates or reduces the need for more invasive in-the-eye injections REDWOOD CITY, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE ...

One day after a subcutaneous injection into the left thigh ... ISR," or reaction at a prior treatment site with subsequent injections. Injection site reactions to etanercept usually occur within ...

you inject into subcutaneous fat, but these patients don’t have that,” said Svetlana Ten, associate professor of pediatrics ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

SAN JOSE, Calif. - Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company with a market capitalization of $48.3 million, today announced promising results from a ...

Lilly is testing both subcutaneous injections and intravenous infusions, according to a company spokesperson. A separate trial conducted by the Washington University School of Medicine will also ...

“The main finding from our study that was very unexpected was getting these subcutaneous injections of M. vaccae prevented the excess of weight gain, excess of visceral adipose tissue that is ...